Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate | Patent Application Number 10310078

10310078
Not Appealed
Patent NumberUS 06965027 B2
Publication NumberUS 20030130292 A1
Filled DateDec 4, 2002
Priority DateDec 6, 2001
Inventor/ApplicantsZheng J. Li
Mark E. Flanagan
Zheng J. Li
Mark E. Flanagan
ExaminesMCKENZIE, THOMAS C
Art Unit1624
Technology Center1600
Assignments
Pfizer Legal Division 2
Current
Pfizer Legal Division 2Pfizer
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.